You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK

Article metrics

Article menu
Epidemiology/Health services research
Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK

 

Online download statistics by month:

Online download statistics by month: January 2023 to March 2024

AbstractFullPdf
Jan 2023803769350
Feb 202333732288
Mar 2023321312122
Apr 202324223063
May 202323121071
Jul 202321821955
Aug 202327227259
Sep 202321820965
Oct 202319419439
Nov 202321220436
Dec 202330328768
Jan 202434834799
Feb 202420519663
Mar 202424524352
Total414940141230